Product Images Methylphenidate Hydrochloride

This is a description for a medication called Methylphenidate Hydrochloride. It is an extended-release capsule and should only be dispensed with the accompanying medication guide. Each capsule contains 60mg of the active ingredient. The usual dosage should be determined through the product literature. The medication needs to be stored at controlled room temperature and protected from moisture. The medication is manufactured by Teva Pharmaceuticals and the lot number is 52-0112.*

The given text seems to be a graph depicting the SKAMP Total Score for a certain time period, showing the score for a certain drug (Netryprenae yachorde) and a placebo. The x-axis denotes the time in hours and the y-axis denotes the score ranging from 0 to 14. So, it is a visual representation of the effect of Netryprenae yachorde compared to a placebo on SKAMP Total Score over time.*

This is a description of a medication with the NDC code 0591-3854-19. It is a once-daily extended-release capsule containing 10 mg of Methylphenidate Hydrochloride. The capsule has "AB54" printed on the cap and "10 mg" on the body for identification. It should be stored in a tight, light-resistant container with a child-resistant closure and protected from moisture. The accompanying product literature should be consulted for dosing information. The medication guide should be provided to each patient by the pharmacist. It is manufactured by Teva Pharmaceuticals and has a lot/exp number of 52-0106.*

This is a medication called Methylphenidate Hydrochloride, which is an extended-release capsule used to treat attention deficit hyperactivity disorder (ADHD). Each capsule contains 15mg of the active ingredient, and should be dispensed in a light-resistant container with child-resistant closure. The pharmacist should provide the patient with a medication guide, and the capsules can be identified by the markings "AB62" on the cap and "15 mg" on the body. Further dosage information can be found in the accompanying literature, and the medication should be stored at room temperature away from moisture. Teva Pharmaceuticals produces this medication, and the lot number and expiration date are not provided.*

This text describes a medicine with the National Drug Code (NDC) of 0591-3869-19, containing Methylphenidate Hydrochloride in Extended-Release Capsules, with a usual dosage to be found in an accompanying product literature. The medication guide should be provided to each patient by the pharmacist, and the capsules are identified by the label AB69 printed on the cap and "20 mg" on the body. The medicine should be dispensed in a tight, light-resistant container with a child-resistant closure and stored away from moisture. The manufacturing company is Teva Pharmaceuticals headquartered in Parsippany, NJ. Lot and expiration date information can also be found in the text.*

This is a description of a medication named Methylphenidate Hydrochloride Extended-Release Capsules with NDC code 0591-3873-19. It has a strength of 30 mg per capsule, and each bottle contains 90 capsules. The medication should only be dispensed upon prescription by a physician to prevent misuse. The accompanying medication guide should be given to the patient with every dispensation. The capsules have identification markings "A73" on the cap and "30 mg" on the body. The medication is stored in a controlled environment to ensure its efficacy, and it should be kept away from children. The manufacturer is Teva Pharmaceuticals, and the lot/expiry code is 52-0109. Instructions are written on the packaging for proper handling and storage.*

This is a medication information sheet for Methylphenidate Hydrochloride Extended-Release Capsules. Each capsule contains 40mg of Methylphenidate Hydrochloride. The capsules are identified by the text "ABG1" on the cap and "40mg" on the body. The usual dosage information is contained within the accompanying product literature. The medication should be stored at controlled room temperature and protected from moisture. The manufacturer is Teva Pharmaceuticals.*

This is a medication guide for NDC 0591-3895-19, which contains Methylphenidate Hydrochloride in extended-release capsules. The pharmacist should dispense a medication guide to each patient. The capsules have "AB95" printed on the cap, "50 mg" on the body, and GTIN 0030591 3895195. The usual dosage instructions are available in the accompanying literature. Store the capsules in a tight light-resistant container with a child-resistant closure, protected from moisture, at 20° to 25°C. This medication is manufactured by Teva Pharmaceuticals.*